Page 217 - Genentech News Today

/PRNewswire/ -- A trial led by City of Hope, one of the largest cancer research and treatment organizations in the nation, contributed to the U.S. Food and...

The US Court of Appeals for the Federal Circuit upheld a district court’s findings of invalidity and noninfringement in a Hatch-Waxman case involving two sets of method patents directed...

US Court of Appeals for the Federal Circuit upheld district court findings of invalidity and noninfringement in Hatch-Waxman case involving two sets of method patents directed to modulating dosages of pirfenidone, drug used to treat idiopathic pulmonary fibrosis.

/PRNewswire/ -- A trial led by City of Hope, one of the largest cancer research and treatment organizations in the nation, contributed to the U.S. Food and...

TUESDAY, Jan. 3, 2023 (HealthDay News) -- The U.S. Food and Drug Administration has approved the immunotherapy drug Tecentriq (atezolizumab) for use in patients with unresectable or metastatic alveolar soft

Leading experts gathered at Yale School of Medicine for the inaugural meeting of the school’s Scientific Advisory Board, to hear about the school's strategic

They have reached out, connected and lobbied to gain access to drugs for their son and his fellow patients.

FoundationOne Liquid CDx, a liquid biopsy test, is the only blood-based CDx approved for the targeted cancer therapy.

WOBURN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!